1 March 2024
Working together to enhance research
Developing kinder treatments for children with Neuroblastoma
In a groundbreaking effort to alleviate the suffering of children battling neuroblastoma, Professor Juliet Gray, a Paediatric Oncology Consultant at University Hospital Southampton, spearheads an innovative research project aimed at developing less painful and less toxic treatments for this rare and aggressive cancer.
Neuroblastoma, predominantly afflicting children under the age of 5, poses a significant threat, with nearly 100 cases reported annually in the UK. Tragically, it accounts for 15% of all childhood cancer deaths, underscoring the urgent need for more effective treatment options.
The prognosis of this disease is generally poor due to its complexity despite intensive chemotherapy, surgery, and radiotherapy. Even after treatment, children who survive often face long-term side effects such as infertility and hearing loss. Treatments available today are highly toxic and a number of children die from acute toxicity of the treatment.
Neuroblastoma, predominantly afflicting children under the age of 5, poses a significant threat, with nearly 100 cases reported annually in the UK. Tragically, it accounts for 15% of all childhood cancer deaths, underscoring the urgent need for more effective treatment options.
The prognosis of this disease is generally poor due to its complexity despite intensive chemotherapy, surgery, and radiotherapy. Even after treatment, children who survive often face long-term side effects such as infertility and hearing loss. Treatments available today are highly toxic and a number of children die from acute toxicity of the treatment
The success of this endeavour hinges on generous support from donors. Contributions will fuel the advancement of groundbreaking treatments, offering hope to countless children and families grappling with the devastating impact of neuroblastoma.
“Your support can revolutionize the way treatment is offered to children,” Professor Gray emphasizes, underscoring the transformative potential of community involvement.
Every donation represents a beacon of hope in the fight against neuroblastoma, enabling researchers to push the boundaries of innovation and compassion in paediatric oncology.
Expressing gratitude for the invaluable support received thus far, Professor Gray extends a heartfelt plea for continued generosity. “It’s thanks to donations like yours that research into new and innovative treatments for Neuroblastoma is possible,” she acknowledges.
Together, let us unite in the pursuit of groundbreaking solutions, transforming the landscape of cancer care and offering renewed hope to children battling neuroblastoma.
Please donate today to help us revolutionise cancer care at University Hospital Southampton.